Lineage Cell Therapeutics stock price target raised to $5 from $3 at Maxim Group Feb. 8, 2021 at 8:14 a.m. ETby Tomi Kilgore BlackRock, Inc.'s Strategic Acquisition of Lineage Cell Therapeutics Inc Shares Apr. 30, 2025 at 9:34 p.m. ETon GuruFocus.com ...